ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZAVESCA
Inborn errors of metabolism
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ZAVESCA Rx

Generic Name and Formulations:
Miglustat 100mg; caps.

Company:
Actelion Pharmaceuticals

Therapeutic Use:

Indications for ZAVESCA:

Mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not feasible.

Adult:

≥18yrs: 100mg 3 times daily; may reduce to 100mg once or twice daily if diarrhea or tremor occurs. Mild renal impairment (CrCl 50–70mL/min): 100mg twice daily. Moderate renal impairment (CrCl 30–50mL/min): 100mg once daily. Severe renal impairment: not recommended.

Children:

<18yrs: not recommended.

Contraindications:

Pregnancy (Cat.X).

Warnings/Precautions:

Perform neurological evaluations at baseline, then periodically at 6-month intervals. Reevaluate and consider discontinuation if signs/symptoms of peripheral neuropathy develop (eg, numbness, tingling). GI disease (eg, inflammatory bowel). Use effective methods of contraception during therapy; men should maintain contraception for 3 months after treatment. Elderly. Labor & delivery. Nursing mothers: not recommended.

Interactions:

May antagonize imiglucerase.

Pharmacological Class:

Glucosylceramide synthase inhibitor.

Adverse Reactions:

Diarrhea, weight loss, tremor, flatulence, abdominal pain, GI disturbances, weakness, headache, dizziness, paresthesia, cramps, thrombocytopenia, reduced spermatogenesis, peripheral neuropathy.

How Supplied:

Caps—18, 90

Sign Up for Free e-newsletters